As mentioned in Chapter 2, passive or active surveillance of adverse drug reactions includes pharmacoepidemiologic studies.2 () studies can be used to identify unexpected or rare safety issues and detect changes in frequency of expected adverse events, and this leads to the reevaluation of a product's benefit–risk ratio.